The bottom line: Other experts in the field tell Axios they agree there’s an urgent need to focus on the AMR Challenge’s “one health” approach to target humans, animals and the environment…
More from Axios here.
The bottom line: Other experts in the field tell Axios they agree there’s an urgent need to focus on the AMR Challenge’s “one health” approach to target humans, animals and the environment…
More from Axios here.
Antibiotics cannot cure COVID. They don’t help a bit. And yet, new data shows that, during the pandemic, COVID patients…
Read MoreThe push for antibiotics to fight fast-evolving superbugs is snagging on a broken business model. Six startups have won Food and Drug…
Read MoreThe recent reintroduction of the Pasteur Bill seeks to address the global threat that antimicrobial-resistant (AMR) infections pose, one subscription…
Read MoreDeveloping a new antibiotic can take as long as 15 years. But in as few as two, the target bug…
Read More